资料单张
INDICATIONS [/za_1290.html#1]
[/za_1290.html#1] [/za_1290.html#1]
CONTRA-INDICATIONS [/za_1290.html#1]
[/za_1290.html#1]
DOSAGE [/za_1290.html#1]
[/za_1290.html#1]
SIDE-EFFECTS [/za_1290.html#1]
[/za_1290.html#1] [/za_1290.html#1]
PREGNANCY [/za_1290.html#1]
[/za_1290.html#1]
OVERDOSE [/za_1290.html#1]
IDENTIFICATION [/za_1290.html#1]
[/za_1290.html#1] PATIENT INFORMATION
IMODIUM® SYRUP
SCHEDULING STATUS:
Schedule 2
PROPRIETARY NAME
(and dosage form):
IMODIUM
®
SYRUP
COMPOSITION
Each mL contains 0,2 mg
LOPERAMIDE
hydrochloride. Methylparaben 0,072% m/v and propylparaben 0,008% m/v as
preservatives.
PHARMACOLOGICAL CLASSIFICATION
A.11.9 Medicines acting on gastro-intestinal tract. Anti-diarrhoeals.
PHARMACOLOGICAL ACTION
IMODIUM inhibits hypermotility by direct action on the bowel wall. Its inhibition of peristalsis is the result of decreasing
the activity of both the longitudinal muscles (preparatory and reflex phases) and the circular muscles (reflex phase).
IMODIUM normalizes the stool in both acute and chronic diarrhoea.
IMODIUM is incompletely absorbed from the gut, and it is almost completely metabolized in the liver where it is
conjugated and excreted via the bile. IMODIUM is mainly eliminated via the faeces.
INDICATIONS
ADULTS AND CHILDREN 6 YEARS AND OLDER: IMODIUM is indicated for the control and symptomatic relief of acute and
chronic nonspecific diarrhoea and inhibits peristalsis and slows intestinal transit time in patients with ileostomies,
colostomies and other intestinal resections.
CHILDREN BELOW 6 YEARS OF AGE: IMODIUM is indicated for inhibition of peristalsis and slowing intestinal transit time.
CONTRA-INDICATIONS
IMODIUM is contra-indicated in patients with a known hypersensitivity to the medicine.
IMODIUM is contra-indicated in infants under
阅读完整的文件
资料单张 